JXHL1900234 | PF-06700841片 | brepocitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-09-21 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2019-09-20 | view |
JXHL1900235 | PF-06700841片 | brepocitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-09-21 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2019-09-20 | view |
JYHB2000055 | PF-06700841片 | brepocitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-01-21 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2020-01-20 | view |
JYHB2000054 | PF-06700841片 | brepocitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-01-21 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2020-01-20 | view |
JYHB2000201 | PF-06700841片 | brepocitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-03-14 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-05-22 | view |
JYHB2000202 | PF-06700841片 | brepocitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-03-14 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-05-22 | view |
JXHB2100007 | PF-06700841片 | brepocitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-01-14 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2021-01-13 | view |
JXHB2100006 | PF-06700841片 | brepocitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-01-14 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2021-01-13 | view |
JXHB2200120 | PF-06700841片 | brepocitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2022-09-01 | | | | | view |
JXHB2200121 | PF-06700841片 | brepocitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2022-09-01 | | | | | view |